Stock screener

MCRB

Conviction 0HealthcareScan · Mon, Aug 10, 2026
MCRB$4.92+1.03%
ResistanceSupportVol 14Insider sell
63 bars
4
Vol MA14 61.38K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Seres Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.serestherapeutics.com
Price4.92
Change+1.03%
Gap+2.46%
Rel volume0.96×
Avg volume66.49K
Avg $ vol335.89K
SMA 205.05
SMA 506.14
SMA 20010.83
Price vs 50-19.83%
Price vs 200-54.55%
MA stackbearish
50/200 cross
Supertrenddown · 6.10
RSI (14)39
MACD hist0.06
MACD crossbull · 4d
Stoch %K / %D31 / 26
ADX (14)26
+DI / −DI15 / 18
RSI divergence
MACD divergenceBullish
ATR %+9.45%
ADR %7.90%
52w high28.63
52w low4.65
From 52w high-82.82%
Above 52w low+5.81%
New 52w highNo
SqueezeOn · 2d
Bollinger width17.73%
%B0.36
Donchian pos29.62%
Donchian high5.70
Donchian low4.59
AVWAP (52w high)11.58
vs AVWAP high-57.50%
AVWAP (52w low)4.94
vs AVWAP low-0.46%
OBV trendDown
Chaikin MF (20)-0.29
Today vs 20d0.96×
Avg vol (14d)61.38K
Avg vol (20d)66.49K
Avg $ vol (20d)335.89K
Market cap48.91M
RS 3m (vs SPY)-42.61%
RS 6m (vs SPY)-77.77%
RS line new highNo
Trend template0/8
Technical rank5.9
1 week-2.19%
1 month-19.48%
3 months-36.10%
6 months-64.76%
1 year-67.82%
YTD-67.52%
P/E8.59
P/B1.42
P/S6.86
P/FCF56.54
EPS0.6400
Div yield
ROE16.49%
ROA5.61%
Debt/Eq3.19
Current2.11
EV/EBITDA-1.60
Gross margin
Net margin79.91%
Rev growth-95.05%
EPS growth4088.24%
Price target
Target upside
Analyst rating
Institutional
Ent. value143.32M
Revenue351K
Net income4.58M
Gross profit
Free cash flow865K
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out9.68M
Employees66
ListedFri, Jun 26, 2015
Free float6.57M
Float %72.7%
Short interest303.42K
Days to cover2.0d
Short volume47.7%
Squeeze score24 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction0 / 100
Pattern quality
Tech rank5.9 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance7.83
Support4.65
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MCRB

All disclosures →
No recent disclosed trades by Congress in MCRB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MCRB · 10 buys

InsiderSideShares
Dere Willard H
Director · Stock Option (right to buy) · 2026-07-08
Grant6.5K
DesRosier Thomas
See Remarks · Stock Option (right to buy) · 2026-07-08
Grant7.5K
Fraser Claire
Director · Stock Option (right to buy) · 2026-07-08
Grant6.5K
Graves Kurt
Director · Stock Option (right to buy) · 2026-07-08
Grant6.5K
Henn Matthew R
See Remarks · Stock Option (right to buy) · 2026-07-08
Grant25K
Thorell Marella
See Remarks · Stock Option (right to buy) · 2026-07-08
Grant7.5K
Ausiello Dennis A
Director · Stock Option (right to buy) · 2026-07-08
Grant6.5K
Berenson Stephen
Director · Stock Option (right to buy) · 2026-07-08
Grant6.5K
Brady Kelly
See Remarks · Stock Option (right to buy) · 2026-07-08
Grant18.75K
Kender Richard N
See Remarks · Stock Option (right to buy) · 2026-07-08
Grant50K

SEC filings

EDGAR filings in MCRB · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.